Can I still get compounded semaglutide?

Yes, from a licensed 503A pharmacy with a real prescription that documents a clinical reason. The cheap telehealth supply that powered 2023 and 2024 has largely shut down or moved to other products.

Is compounded semaglutide safe?

A compounded product from a credentialed 503A pharmacy using semaglutide base from a US-registered API supplier is generally safe at known doses. A salt-form or gray-market product is a different category and the FDA has warned against it.

Is compounded semaglutide the same as Ozempic?

The active ingredient is semaglutide in both, but compounded versions vary in concentration, preservatives, additives like B12, and sometimes in the chemical form (base versus salt). Brand product is a fixed formulation; compounded is not.

Is semaglutide with B12 safe?

B12 is generally safe at typical compounded doses, but the FDA does not view "semaglutide plus B12" as a meaningful clinical improvement over plain semaglutide, and explicitly considers the combination still subject to the "essentially a copy" restriction.

Why is compounded semaglutide cheap?

It was cheap in 2023-2024 because 503B outsourcing facilities were producing it in volume under the shortage exception. With the shortage resolved, that volume is gone, and prices in 2026 from legitimate operations are substantially higher than the old telehealth pricing.

How much is compounded semaglutide in 2026?

Real 503A patient-specific compounding generally runs several hundred dollars a month or more. Sub-$150 monthly pricing in 2026 is a signal that the operation is either non-compliant or selling a salt-form or research-grade product.

Does insurance cover compounded semaglutide?

Commercial insurance and Medicare almost never cover compounded GLP-1s. Some FSA and HSA plans will reimburse with documentation. Brand Ozempic or Wegovy with insurance coverage is often cheaper than cash-pay compounded.

How long does compounded semaglutide last in the fridge?

Beyond-use dates depend on the preservative system and the pharmacy. Common range: 28 to 56 days after first puncture, refrigerated at 36 to 46 F. Use the date on your label, not a generic value.

Is compounded semaglutide going away?

Mass-market compounded semaglutide largely went away in mid-2025. Legitimate patient-specific compounding for documented clinical need remains legal in 2026 but is a much smaller market.

How is compounded semaglutide made?

A licensed compounding pharmacy combines semaglutide API (ideally semaglutide base from a US-registered source) with a sterile water-for-injection vehicle, a preservative system, and sometimes additional ingredients, then fills sterile vials under USP standards (503A) or cGMP (503B).

What is semaglutide sodium versus semaglutide base?

Semaglutide base is the active ingredient in FDA-approved Ozempic and Wegovy. Semaglutide sodium and semaglutide acetate are salt forms of the molecule, often used by lower-cost compounders. The FDA considers the salts different active ingredients with no established safety or efficacy data.

How do I know if a compounding pharmacy is legitimate?

It is licensed by the state board of pharmacy (verifiable online), discloses whether it is 503A or 503B, names a real pharmacist you can reach, ships with a labeled vial including beyond-use date and lot number, and answers source-of-API questions directly.

Compounded Semaglutide in 2026: What's Legal, What's Not, and What to Ask Before You Pay

Summary: The FDA declared the semaglutide shortage resolved in early 2025, which made bulk compounded copies illegal in 2026. Patient-specific compounds for a documented medical need are still legal, but the legitimate supply is much narrower than it was in 2023 and 2024.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short version: compounded semaglutide is still legally available in 2026, but the rules changed. The FDA declared the semaglutide shortage resolved in February 2025 ^[1], which means the broad "shortage exception" that powered the 2023 and 2024 telehealth boom no longer applies. What is still legal is patient-specific compounding, where a licensed prescriber documents a clinical reason a particular patient needs a non-commercial formulation. Bulk pharmacy production of "essentially a copy" of Ozempic or Wegovy is not.

If you bought compounded semaglutide in 2024 from a $199-a-month clinic, the supply that fed that price collapsed. The compounded vials you can buy today exist under a narrower legal framework, and the prices reflect it.

Compounded semaglutide sits inside the broader category of weight loss injections, alongside FDA-approved products like Ozempic, Wegovy, Mounjaro, and Zepbound. What sets compounded versions apart is who makes them, how they are regulated, and what is actually in the vial.

What "compounded" actually means

Compounding is a pharmacy combining, mixing, altering, or repackaging drug ingredients to create a medication that is not available off the shelf in that exact form ^[2]. It is a real and longstanding part of pharmacy practice. Examples that are not controversial: a child who needs an antibiotic as a flavored liquid instead of a tablet, a patient with a dye allergy who needs a hypoallergenic version of a chronic medication, a hospital that needs a specific concentration of a drug for IV use that the manufacturer does not produce.

Compounded drugs are not FDA approved. The FDA does not review them for safety, efficacy, or quality before they ship ^[1]. The pharmacy is responsible for the formulation, the sterility, the labeling, and the beyond-use date. Two pharmacies compounding semaglutide are not making the same product.

503A versus 503B: the distinction that drives everything

US compounding pharmacies operate under two sections of the Food, Drug, and Cosmetic Act, and the difference matters ^[2].

	503A pharmacy	503B outsourcing facility
Patient-specific	Yes. Each compound is made for an individual patient with a valid prescription.	Not required. Can compound in bulk for office use without patient names.
Regulator	State board of pharmacy (FDA also has authority).	FDA, with cGMP inspections.
Quality standard	USP compounding standards.	Current Good Manufacturing Practice (cGMP), the same standard as drug manufacturers.
Can copy a commercial product?	Only if not "essentially a copy" of an FDA-approved drug, unless a shortage exception applies.	Same restriction.
Typical example	An independent pharmacy mixing a custom semaglutide dose for a specific patient.	A facility shipping prefilled syringes to a weight-loss clinic for in-office administration.

Both 503A and 503B were temporarily allowed to compound semaglutide in bulk during the FDA's official shortage. Both lost that pathway when the shortage resolved. The narrower path that remains, individualized prescriptions for specific medical need, applies primarily to 503A.

The shortage timeline that closed the door

Semaglutide injection (Ozempic and Wegovy) went on the FDA drug shortage list in 2022 and stayed there through most of 2024 ^[3]. During that period, compounders could legally produce copies of semaglutide under Section 503A and 503B exceptions, because federal law allows compounding from a drug on the shortage list even if an FDA-approved version exists.

In February 2025, the FDA declared the semaglutide shortage resolved ^[1]. The agency gave compounders a wind-down period (about 60 days for 503A pharmacies, 90 days for 503B facilities) before enforcement began. By mid-2025, large-scale compounded semaglutide from telehealth clinics had largely shut down or pivoted to other products.

What is still legal in 2026

A 503A pharmacy can still compound semaglutide when a specific patient has a documented clinical reason that the commercial product will not work for them. The FDA's guidance lists examples like:

A documented allergy to an excipient in the FDA-approved version.
A clinical need for a dose strength that is not commercially available (a true intermediate strength, not just a cheaper version of an existing pen).
A formulation requirement the brand cannot meet, like a preservative-free version for a patient with a documented sensitivity.

The prescription has to be for a specific named patient, written by a licensed prescriber, and the clinical rationale should be in the chart. The pharmacy needs to be able to defend the compound if asked. Mass-produced vials sold to anyone who fills out a telehealth form do not fit this picture.

How compounded semaglutide actually differs from brand

Even when it is legally compounded, what comes out of the pharmacy is not identical to Ozempic or Wegovy. The active ingredient is semaglutide, but the formulation choices vary.

Concentration

Brand semaglutide pens are at fixed strengths. Ozempic comes in 0.25, 0.5, 1, and 2 mg per click. Wegovy comes in 0.25, 0.5, 1, 1.7, and 2.4 mg per injection. Compounded vials are typically supplied at a single concentration in milligrams per milliliter, often 2.5 mg/mL or 5 mg/mL, and you measure your dose with an insulin syringe. That changes how you draw, how you titrate, and how easy it is to make a math error.

Base versus salt

This is the technical question that started getting press in 2024 and matters in 2026. The FDA-approved semaglutide products use semaglutide as the active ingredient. Some compounders began using semaglutide sodium or semaglutide acetate, the salt forms of the molecule, often sourced from non-US API suppliers. The FDA's position: salt forms are different active ingredients from the semaglutide in Ozempic and Wegovy, and there is no established safety, efficacy, or pharmacokinetic data for the salts in humans ^[4]. The FDA has issued warning letters and consumer alerts on this point.

This is not always a deal-breaker, but it is worth understanding. A reputable 503A compounding pharmacy using semaglutide base from a registered US API supplier is a different product from a gray-market vial of semaglutide sodium with no chain of custody. Ask. The pharmacy should tell you the form and the source.

B12 and other additives

Many compounded semaglutide products were sold as "semaglutide with B12" or "semaglutide / cyanocobalamin." The marketing claim was that B12 helps energy and offsets fatigue from appetite suppression. The clinical evidence for B12 doing anything functional in this context is thin. The FDA's 2025 guidance specifically called out semaglutide-plus-B12 as a combination that does not automatically escape the "essentially a copy" restriction ^[1]. If a pharmacy is selling you semaglutide-B12 in 2026 and presenting it as a workaround to compounding rules, that is a flag.

Preservatives

Brand semaglutide pens contain phenol as a preservative. Compounded vials may use a different preservative system (benzyl alcohol is common in compounded peptides), or be supplied as preservative-free single-dose vials that you must use within a short window. The injection-site sting profile and the stability profile both depend on this choice.

How to spot a sketchy supplier

In 2026, the compounding pharmacies still legitimately producing semaglutide are smaller in number than in 2024, and the rest of the market is full of operators who are either ignoring the new FDA enforcement framework or selling unregulated "research peptides" that are not legally for human use at all.

Things a legitimate operation does:

Requires a real prescriber consultation, not a 30-second intake form.
Tells you the name of the compounding pharmacy filling your prescription, with a license number you can verify on the state board of pharmacy site.
Provides a vial label with the concentration, beyond-use date, lot number, and storage instructions.
Uses semaglutide base from a US-registered API supplier and will say so if you ask.
Has a pharmacist available to answer dosing and storage questions.
Discloses adverse events to FDA MedWatch when they occur.

Things that should make you walk away:

"FDA registered" claims (compounding pharmacies are not FDA approved; the only thing that is registered is the facility itself, and 503A pharmacies generally are not).
No prescription required, or a "prescription" issued by a doctor who never spoke to you in any format.
Salt-form semaglutide marketed as equivalent to Ozempic with no acknowledgment of the FDA's position.
Pricing that is dramatically below what a legitimate 503A pharmacy charges in 2026 (the very low prices of 2023-2024 are no longer compatible with the legal framework).
Vials shipped from outside the US without proper customs documentation.

What to ask before paying

Five questions, in order of priority. A real provider can answer all of them quickly.

Is this a 503A or 503B pharmacy, and what is the pharmacy's name and state license number?
Is the semaglutide in this product semaglutide base or a salt form (sodium or acetate)?
What is the concentration in mg/mL, and what insulin syringe units correspond to my prescribed dose?
Beyond-use date and storage: refrigerated, what temperature range, and for how many days after first puncture?
Who do I call if I have a reaction or a question, and is a pharmacist actually available?

If the answer to any of these is "we don't share that" or a vague marketing reply, that is the answer.

Pricing reality after the resolution

Before the shortage ended, compounded semaglutide from telehealth clinics ran $150 to $300 per month, sometimes lower with introductory pricing. The supply that produced those prices depended on 503B outsourcing facilities producing semaglutide in volume under the shortage exception. That volume is gone in 2026.

Legitimate patient-specific 503A compounding in 2026 typically runs higher, in the range of a real specialty pharmacy compound rather than a commodity. A monthly supply of compounded semaglutide from a credible 503A pharmacy in 2026 is generally several hundred dollars at minimum. If you see $99-a-month pricing, the operation is either ignoring federal enforcement, selling salt-form product, or selling something other than what is advertised.

Brand Ozempic and Wegovy with insurance coverage can land at a copay similar to or lower than out-of-pocket compounded pricing. Lilly's and Novo Nordisk's direct-to-consumer cash programs (LillyDirect and the equivalent for Novo) have narrowed the price gap on brand product for cash-pay patients. The economics that made compounded the obvious choice in 2023 are no longer obvious.

Does compounded semaglutide work as well as Ozempic?

If the active ingredient is true semaglutide base, at the same molar dose, the pharmacology is the same molecule. Reports of compounded semaglutide "not working" usually trace to one of three things: a salt-form product with different pharmacokinetics, a sub-potent batch, or a dosing math error from converting brand-pen click numbers to insulin-syringe units. The molecule does not care which pharmacy made it. The supply chain does.

There is no published head-to-head trial of compounded semaglutide versus brand. The pivotal weight-loss data (STEP-1 through STEP-8 for Wegovy, SUSTAIN-6 for cardiovascular outcomes in Ozempic) was generated with branded product. Compounded versions inherit those results only if the formulation actually delivers the same drug at the same dose.

Storage and shelf life

Compounded semaglutide is typically refrigerated at 36 to 46 F (2 to 8 C). Once a multi-dose vial is punctured, beyond-use dates vary by pharmacy and preservative system. A common range is 28 to 56 days. The exact number is on your label. Use that number, not a generic value from a forum.

Do not freeze semaglutide. If a vial has been frozen and thawed, the peptide can aggregate and lose potency. Travel with a small insulated cooler with an ice pack, not direct contact with ice. If you are unsure whether a vial has been temperature-abused, the pharmacy can usually tell you what to look for visually (cloudiness, particulates, color shift) but a clear-looking vial is not a guarantee.

Insurance coverage

Compounded semaglutide is almost never covered by commercial insurance. Insurers cover FDA-approved products. Some flexible spending and health savings accounts will reimburse compounded prescriptions if the pharmacy provides an itemized receipt and a documented clinical rationale, but this varies by plan. Medicare does not cover compounded semaglutide. Medicaid generally does not cover it either.

What the FDA can and cannot do

The FDA's enforcement against compounded GLP-1 producers in 2025 and 2026 focused on operations selling product that is "essentially a copy" of FDA-approved semaglutide outside of the shortage exception, and on operations using non-API-grade semaglutide (research-grade, salt-form, or unregistered foreign source). The agency has limited inspection capacity, particularly for 503A pharmacies which are primarily state-regulated, so enforcement is uneven. The legal exposure for the pharmacy is real; the legal exposure for a patient buying a compounded prescription written by a licensed US prescriber is essentially zero, but the safety exposure is yours to manage.

When compounded semaglutide does make sense

There are still patients for whom a legitimate compounded prescription is the right call: a documented allergy to a brand-product excipient, a need for a specific intermediate dose, or a clinical situation where a personalized formulation is genuinely warranted. The path to that is a prescriber who knows you, a 503A pharmacy with a real license and a real pharmacist, and a clear written rationale in the chart.

That is not the same product the telehealth ad on your social media feed is selling for $129 a month. The legal framework that produced that price ended. What replaced it is narrower, more expensive, and harder to find, which is uncomfortable but is the regulatory state of compounded semaglutide in 2026.

Frequently asked questions

Is compounded semaglutide legal in 2026?: Patient-specific 503A compounding for a documented medical need is legal. Bulk production of "essentially a copy" of Ozempic or Wegovy is not, because the FDA declared the semaglutide shortage resolved in February 2025.
Can I still get compounded semaglutide?: Yes, from a licensed 503A pharmacy with a real prescription that documents a clinical reason. The cheap telehealth supply that powered 2023 and 2024 has largely shut down or moved to other products.
Is compounded semaglutide safe?: A compounded product from a credentialed 503A pharmacy using semaglutide base from a US-registered API supplier is generally safe at known doses. A salt-form or gray-market product is a different category and the FDA has warned against it.
Is compounded semaglutide the same as Ozempic?: The active ingredient is semaglutide in both, but compounded versions vary in concentration, preservatives, additives like B12, and sometimes in the chemical form (base versus salt). Brand product is a fixed formulation; compounded is not.
Is semaglutide with B12 safe?: B12 is generally safe at typical compounded doses, but the FDA does not view "semaglutide plus B12" as a meaningful clinical improvement over plain semaglutide, and explicitly considers the combination still subject to the "essentially a copy" restriction.
Why is compounded semaglutide cheap?: It was cheap in 2023-2024 because 503B outsourcing facilities were producing it in volume under the shortage exception. With the shortage resolved, that volume is gone, and prices in 2026 from legitimate operations are substantially higher than the old telehealth pricing.
How much is compounded semaglutide in 2026?: Real 503A patient-specific compounding generally runs several hundred dollars a month or more. Sub-$150 monthly pricing in 2026 is a signal that the operation is either non-compliant or selling a salt-form or research-grade product.
Does insurance cover compounded semaglutide?: Commercial insurance and Medicare almost never cover compounded GLP-1s. Some FSA and HSA plans will reimburse with documentation. Brand Ozempic or Wegovy with insurance coverage is often cheaper than cash-pay compounded.
How long does compounded semaglutide last in the fridge?: Beyond-use dates depend on the preservative system and the pharmacy. Common range: 28 to 56 days after first puncture, refrigerated at 36 to 46 F. Use the date on your label, not a generic value.
Is compounded semaglutide going away?: Mass-market compounded semaglutide largely went away in mid-2025. Legitimate patient-specific compounding for documented clinical need remains legal in 2026 but is a much smaller market.
How is compounded semaglutide made?: A licensed compounding pharmacy combines semaglutide API (ideally semaglutide base from a US-registered source) with a sterile water-for-injection vehicle, a preservative system, and sometimes additional ingredients, then fills sterile vials under USP standards (503A) or cGMP (503B).
What is semaglutide sodium versus semaglutide base?: Semaglutide base is the active ingredient in FDA-approved Ozempic and Wegovy. Semaglutide sodium and semaglutide acetate are salt forms of the molecule, often used by lower-cost compounders. The FDA considers the salts different active ingredients with no established safety or efficacy data.
How do I know if a compounding pharmacy is legitimate?: It is licensed by the state board of pharmacy (verifiable online), discloses whether it is 503A or 503B, names a real pharmacist you can reach, ships with a labeled vial including beyond-use date and lot number, and answers source-of-API questions directly.

What this article does not cover

Specific state pharmacy board rules, individual telehealth provider reviews, and dosing protocols for compounded vials are covered on their own pages. The exact mL-to-mg conversion math for a 5 mg/mL or 2.5 mg/mL compounded semaglutide vial has its own dedicated reference. This page is the regulatory and safety frame around the question of whether and where to buy. The clinical injection mechanics are a different problem.